The JAMA study finds individual blood pressure responses to dietary sodium variations are consistent across different subgroups, including those on antihypertensive medications, suggesting a universal effect of sodium intake on blood pressure in a diverse population.
Coherus and Junshi’s PD-1 inhibitor approved for nasopharyngeal carcinoma – Pharmaceutical Technology
Coherus licensed Loqtorzi from Junshi for marketing in the US and Canada in February 2021. Image Credit: Prostock-studio / Shutterstock. The US Food and Drug
October 30, 2023